Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 8/20 | 0.46 |
| ▸ | TYR | P14679 | 2/20 | 0.42 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.42 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28123711 | 0.88 | ERN1 (0.52) | ERN1TYRTRIM24TRIM33ESR1 | |
| SCHEMBL3469126 | 0.82 | ERN1 (0.46) | ERN1TYRTRIM24TRIM33ACHE | |
| SCHEMBL1981683 | 0.82 | ERN1 (0.64) | ERN1TYRTRIM24TRIM33ACHE | |
| SCHEMBL12311286 | 0.79 | CYP3A4 (0.63) | ERN1TYRTRIM24TRIM33CYP3A4 | |
| SCHEMBL13447874 | 0.78 | ERN1 (0.53) | ERN1TYRTRIM24TRIM33ACHE | |
| SCHEMBL12957472 | 0.78 | ERN1 (0.53) | ERN1TYRTRIM24TRIM33ACHE | |
| SCHEMBL69626 | 0.77 | ESR1 (0.44) | ACHECYP3A4MEN1HPGDKMT2A | |
| SCHEMBL29459679 | 0.76 | ERN1 (0.50) | ERN1TYRTRIM24TRIM33ESR1 | |
| SCHEMBL1003422 | 0.76 | ERN1 (0.50) | ERN1TYRTRIM24TRIM33ESR1 | |
| SCHEMBL10118325 | 0.74 | ERN1 (0.42) | ERN1TYRTRIM24TRIM33CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0961615-A4 | ANTIMICROBIAL AGENT | DORLIN PHARM INC (US) | 2002-09-11 | — | — | EP | claimed |
| EP-0961615-A1 | ANTIMICROBIAL AGENT | Dorlin Pharmaceuticals, Inc. (US) | 1999-12-08 | — | — | EP | claimed |
| US-5910509-A | ADMINISTERING SUBSTITUTED ISOCHROMENE DERIVATIVE; FUNGICIDES | DORLIN PHARMACEUTICALS, INC. | 1999-06-08 | — | — | US | claimed |
| US-5859027-A | Antimicrobial agent | CHEKTEC CORPORATION (US) | 1999-01-12 | — | — | US | claimed |
| WO-1998037890-A1 | ANTIMICROBIAL AGENT | DORLIN PHARMACEUTICALS, INC. (US) | 1998-09-03 | — | — | WO | claimed |
| US-9623123-B2 | Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2017-04-18 | — | — | US | disclosed |
| US-9623123-B2 | Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2017-04-18 | — | — | US | disclosed |
| US-20170014532-A1 | FLUORESCENT CONJUGATED POLYMERS WITH A BODIPY-BASED BACKBONE AND USES THEREOF | UNIV MICHIGAN TECH (US) | 2017-01-19 | — | — | US | disclosed |
| US-20170014532-A1 | FLUORESCENT CONJUGATED POLYMERS WITH A BODIPY-BASED BACKBONE AND USES THEREOF | UNIV MICHIGAN TECH (US) | 2017-01-19 | — | — | US | disclosed |
| US-9412949-B2 | Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2016-08-09 | — | — | US | disclosed |
| US-9412949-B2 | Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2016-08-09 | — | — | US | disclosed |
| US-20120070382-A1 | FLUORESCENT CONJUGATED POLYMERS WITH A BODIPY-BASED BACKBONE AND USES THEREOF | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2012-03-22 | — | — | US | disclosed |
| US-20120070382-A1 | FLUORESCENT CONJUGATED POLYMERS WITH A BODIPY-BASED BACKBONE AND USES THEREOF | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2012-03-22 | — | — | US | disclosed |
| EP-0961615-A4 | ANTIMICROBIAL AGENT | DORLIN PHARM INC (US) | 2002-09-11 | — | — | EP | disclosed |
| EP-0961615-A1 | ANTIMICROBIAL AGENT | Dorlin Pharmaceuticals, Inc. (US) | 1999-12-08 | — | — | EP | disclosed |
| US-5910509-A | ADMINISTERING SUBSTITUTED ISOCHROMENE DERIVATIVE; FUNGICIDES | DORLIN PHARMACEUTICALS, INC. | 1999-06-08 | — | — | US | disclosed |
| US-5859027-A | Antimicrobial agent | CHEKTEC CORPORATION (US) | 1999-01-12 | — | — | US | disclosed |
| WO-1998037891-A1 | ANTIMICROBIAL AGENT FOR AGRICULTURE | DORLIN PHARMACEUTICALS, INC. (US) | 1998-09-03 | — | — | WO | disclosed |
| WO-1998037890-A1 | ANTIMICROBIAL AGENT | DORLIN PHARMACEUTICALS, INC. (US) | 1998-09-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170014532-A1 | FLUORESCENT CONJUGATED POLYMERS WITH A BODIPY-BASED BACKBONE AND USES THEREOF | TLR3, TLR5, PARP15 | ERN1 2316/4885TYR 2195/4885TRIM24 819/4885 |
| US-20120070382-A1 | FLUORESCENT CONJUGATED POLYMERS WITH A BODIPY-BASED BACKBONE AND USES THEREOF | TLR3, TLR5, PARP15 | ERN1 2316/4885TYR 2195/4885TRIM24 819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.